Package 51991-074-01

Brand: ascomp with codeine

Generic: butalbital, aspirin, caffeine and codeine phosphate
NDC Package

Package Facts

Identity

Package NDC 51991-074-01
Digits Only 5199107401
Product NDC 51991-074
Description

100 CAPSULE in 1 BOTTLE, PLASTIC (51991-074-01)

Marketing

Marketing Status
Marketed Since 2009-05-01
Brand ascomp with codeine
Generic butalbital, aspirin, caffeine and codeine phosphate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a41a61f0-e530-4fb5-8198-bdc866219e33", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175693", "M0002177", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["R16CO5Y76E", "KHS0AZ4JVK", "3G6A5W338E", "GSL05Y1MN6"], "rxcui": ["994237", "994239"], "spl_set_id": ["243a6aea-0f48-42a9-a85e-ff247ab94336"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Barbiturates [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Barbiturate [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE, PLASTIC (51991-074-01)", "package_ndc": "51991-074-01", "marketing_start_date": "20090501"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE, PLASTIC (51991-074-05)", "package_ndc": "51991-074-05", "marketing_start_date": "20090501"}], "brand_name": "Ascomp with Codeine", "product_id": "51991-074_a41a61f0-e530-4fb5-8198-bdc866219e33", "dosage_form": "CAPSULE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Barbiturate [EPC]", "Barbiturates [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Full Opioid Agonists [MoA]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Opioid Agonist [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "51991-074", "dea_schedule": "CIII", "generic_name": "Butalbital, Aspirin, Caffeine and Codeine Phosphate", "labeler_name": "Breckenridge Pharmaceutical, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ascomp with Codeine", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}, {"name": "BUTALBITAL", "strength": "50 mg/1"}, {"name": "CAFFEINE", "strength": "40 mg/1"}, {"name": "CODEINE PHOSPHATE", "strength": "30 mg/1"}], "application_number": "ANDA075231", "marketing_category": "ANDA", "marketing_start_date": "20090501", "listing_expiration_date": "20271231"}